Schmidt & Clark, LLP | A National Law Firm

Symbicort Inhaler Lawsuit


symbicort lawsuit, lawyer, law firm, attorneyThe U.S. Food & Drug Administration (FDA) recently required AstraZeneca, the maker of the popular asthma inhaler Symbicort (budesonide and formoterol) to add new warnings on the product labeling warning of an increased risk of hospitalization and death.

Do I Have a Symbicort Lawsuit? If you or a loved one have used a Symbicort inhaler and subsequently suffered from a serious injury or unfortunate death, you should contact us immediately. You may be entitled to compensation for your injuries or loss and we can help.

The Problem With LABAs

Symbicort belongs to a class of inhalers called Long-Acting Beta-Agonists (LABAs).

Symbicort inhalers relax the muscles in bronchial passages, allowing more air to flow. The medication generally provides immediate relief to asthma sufferers but unfortunately, does not treat the underlying inflammation. This creates the risk of a life-threatening condition.

Attention Attorneys:  Schmidt & Clark considers a referral from another law firm to be one of the greatest compliments. Our law firm has built a reputation for success and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.